Developing a multi-component immune model for evaluating the risk of respiratory illness in athletes

Maree Gleeson, David B Pyne, Lisa J Elkington, Sharron T. Hall, John R. Attia, Christopher Oldmeadow, Lisa G. Wood, Robin Callister

    Research output: Contribution to journalArticle

    7 Citations (Scopus)
    2 Downloads (Pure)

    Abstract

    Clinical and laboratory identification of the underlying risk of respiratory illness in athletes has proved problematic. The aim of this study was to determine whether clinical data, combined with immune responses to standardised exercise protocols and genetic cytokine polymorphism status, could identify the risk of respiratory illness (symptoms) in a cohort of highly-trained athletes. Male endurance athletes (n=16; VO2max 66.5 ± 5.1 mL.kg-1.min-1) underwent a clinical evaluation of known risk factors by a physician and comprehensive laboratory analysis of immune responses both at rest and after two cycling ergometer tests: 60 min at 65% VO2max (LONG); and 6 x 3 min intervals at 90% VO2max (INTENSE). Blood tests were performed to determine Epstein Barr virus (EBV) status and DNA was genotyped for a panel of cytokine gene polymorphisms. Saliva was collected for measurement of IgA and detection of EBV DNA. Athletes were then followed for 9 months for self-reported episodes of respiratory illness, with confirmation of the underlying cause by a sports physician. There were no associations with risk of respiratory illness identified for any parameter assessed in the clinical evaluations. The laboratory parameters associated with an increased risk of respiratory illnesses in highly-trained athletes were cytokine gene polymorphisms for the high expression of IL-6 and IFN-ɣ; expression of EBV-DNA in saliva; and low levels of salivary IgA concentration. A genetic risk score was developed for the cumulative number of minor alleles for the cytokines evaluated. Athletes prone to recurrent respiratory illness were more likely to have immune disturbances that allow viral reactivation, and a genetic predisposition to pro-inflammatory cytokine responses to intense exercise.

    Original languageEnglish
    Pages (from-to)52-64
    Number of pages13
    JournalExercise Immunology Review
    Volume23
    Publication statusPublished - 2017

    Cite this

    Gleeson, M., Pyne, D. B., Elkington, L. J., Hall, S. T., Attia, J. R., Oldmeadow, C., ... Callister, R. (2017). Developing a multi-component immune model for evaluating the risk of respiratory illness in athletes. Exercise Immunology Review, 23, 52-64.
    Gleeson, Maree ; Pyne, David B ; Elkington, Lisa J ; Hall, Sharron T. ; Attia, John R. ; Oldmeadow, Christopher ; Wood, Lisa G. ; Callister, Robin. / Developing a multi-component immune model for evaluating the risk of respiratory illness in athletes. In: Exercise Immunology Review. 2017 ; Vol. 23. pp. 52-64.
    @article{62c42f6bd60b460aa0d7c602a4e9847a,
    title = "Developing a multi-component immune model for evaluating the risk of respiratory illness in athletes",
    abstract = "Clinical and laboratory identification of the underlying risk of respiratory illness in athletes has proved problematic. The aim of this study was to determine whether clinical data, combined with immune responses to standardised exercise protocols and genetic cytokine polymorphism status, could identify the risk of respiratory illness (symptoms) in a cohort of highly-trained athletes. Male endurance athletes (n=16; VO2max 66.5 ± 5.1 mL.kg-1.min-1) underwent a clinical evaluation of known risk factors by a physician and comprehensive laboratory analysis of immune responses both at rest and after two cycling ergometer tests: 60 min at 65{\%} VO2max (LONG); and 6 x 3 min intervals at 90{\%} VO2max (INTENSE). Blood tests were performed to determine Epstein Barr virus (EBV) status and DNA was genotyped for a panel of cytokine gene polymorphisms. Saliva was collected for measurement of IgA and detection of EBV DNA. Athletes were then followed for 9 months for self-reported episodes of respiratory illness, with confirmation of the underlying cause by a sports physician. There were no associations with risk of respiratory illness identified for any parameter assessed in the clinical evaluations. The laboratory parameters associated with an increased risk of respiratory illnesses in highly-trained athletes were cytokine gene polymorphisms for the high expression of IL-6 and IFN-ɣ; expression of EBV-DNA in saliva; and low levels of salivary IgA concentration. A genetic risk score was developed for the cumulative number of minor alleles for the cytokines evaluated. Athletes prone to recurrent respiratory illness were more likely to have immune disturbances that allow viral reactivation, and a genetic predisposition to pro-inflammatory cytokine responses to intense exercise.",
    keywords = "exercise, athletes, respiratory infections, inflammation",
    author = "Maree Gleeson and Pyne, {David B} and Elkington, {Lisa J} and Hall, {Sharron T.} and Attia, {John R.} and Christopher Oldmeadow and Wood, {Lisa G.} and Robin Callister",
    note = "Copyright {\circledC} 2016 International Society of Exercise and Immunology. All rights reserved.",
    year = "2017",
    language = "English",
    volume = "23",
    pages = "52--64",
    journal = "Exercise Immunology Review",
    issn = "1077-5552",
    publisher = "Human Kinetics Publishers Inc.",

    }

    Gleeson, M, Pyne, DB, Elkington, LJ, Hall, ST, Attia, JR, Oldmeadow, C, Wood, LG & Callister, R 2017, 'Developing a multi-component immune model for evaluating the risk of respiratory illness in athletes', Exercise Immunology Review, vol. 23, pp. 52-64.

    Developing a multi-component immune model for evaluating the risk of respiratory illness in athletes. / Gleeson, Maree; Pyne, David B; Elkington, Lisa J; Hall, Sharron T.; Attia, John R.; Oldmeadow, Christopher; Wood, Lisa G.; Callister, Robin.

    In: Exercise Immunology Review, Vol. 23, 2017, p. 52-64.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Developing a multi-component immune model for evaluating the risk of respiratory illness in athletes

    AU - Gleeson, Maree

    AU - Pyne, David B

    AU - Elkington, Lisa J

    AU - Hall, Sharron T.

    AU - Attia, John R.

    AU - Oldmeadow, Christopher

    AU - Wood, Lisa G.

    AU - Callister, Robin

    N1 - Copyright © 2016 International Society of Exercise and Immunology. All rights reserved.

    PY - 2017

    Y1 - 2017

    N2 - Clinical and laboratory identification of the underlying risk of respiratory illness in athletes has proved problematic. The aim of this study was to determine whether clinical data, combined with immune responses to standardised exercise protocols and genetic cytokine polymorphism status, could identify the risk of respiratory illness (symptoms) in a cohort of highly-trained athletes. Male endurance athletes (n=16; VO2max 66.5 ± 5.1 mL.kg-1.min-1) underwent a clinical evaluation of known risk factors by a physician and comprehensive laboratory analysis of immune responses both at rest and after two cycling ergometer tests: 60 min at 65% VO2max (LONG); and 6 x 3 min intervals at 90% VO2max (INTENSE). Blood tests were performed to determine Epstein Barr virus (EBV) status and DNA was genotyped for a panel of cytokine gene polymorphisms. Saliva was collected for measurement of IgA and detection of EBV DNA. Athletes were then followed for 9 months for self-reported episodes of respiratory illness, with confirmation of the underlying cause by a sports physician. There were no associations with risk of respiratory illness identified for any parameter assessed in the clinical evaluations. The laboratory parameters associated with an increased risk of respiratory illnesses in highly-trained athletes were cytokine gene polymorphisms for the high expression of IL-6 and IFN-ɣ; expression of EBV-DNA in saliva; and low levels of salivary IgA concentration. A genetic risk score was developed for the cumulative number of minor alleles for the cytokines evaluated. Athletes prone to recurrent respiratory illness were more likely to have immune disturbances that allow viral reactivation, and a genetic predisposition to pro-inflammatory cytokine responses to intense exercise.

    AB - Clinical and laboratory identification of the underlying risk of respiratory illness in athletes has proved problematic. The aim of this study was to determine whether clinical data, combined with immune responses to standardised exercise protocols and genetic cytokine polymorphism status, could identify the risk of respiratory illness (symptoms) in a cohort of highly-trained athletes. Male endurance athletes (n=16; VO2max 66.5 ± 5.1 mL.kg-1.min-1) underwent a clinical evaluation of known risk factors by a physician and comprehensive laboratory analysis of immune responses both at rest and after two cycling ergometer tests: 60 min at 65% VO2max (LONG); and 6 x 3 min intervals at 90% VO2max (INTENSE). Blood tests were performed to determine Epstein Barr virus (EBV) status and DNA was genotyped for a panel of cytokine gene polymorphisms. Saliva was collected for measurement of IgA and detection of EBV DNA. Athletes were then followed for 9 months for self-reported episodes of respiratory illness, with confirmation of the underlying cause by a sports physician. There were no associations with risk of respiratory illness identified for any parameter assessed in the clinical evaluations. The laboratory parameters associated with an increased risk of respiratory illnesses in highly-trained athletes were cytokine gene polymorphisms for the high expression of IL-6 and IFN-ɣ; expression of EBV-DNA in saliva; and low levels of salivary IgA concentration. A genetic risk score was developed for the cumulative number of minor alleles for the cytokines evaluated. Athletes prone to recurrent respiratory illness were more likely to have immune disturbances that allow viral reactivation, and a genetic predisposition to pro-inflammatory cytokine responses to intense exercise.

    KW - exercise

    KW - athletes

    KW - respiratory infections

    KW - inflammation

    UR - http://www.scopus.com/inward/record.url?scp=85045481831&partnerID=8YFLogxK

    M3 - Article

    VL - 23

    SP - 52

    EP - 64

    JO - Exercise Immunology Review

    JF - Exercise Immunology Review

    SN - 1077-5552

    ER -